Lifeline Vascular Access receives re-accreditation from Joint Commission

Lifeline Vascular AccessSM, the nation’s leading provider of vascular access management services, announced today that it has been re-accredited by the Joint Commission - demonstrating compliance with the Joint Commission’s national standards for health care quality and safety. Lifeline Vascular Access was awarded its first accreditation in 2006 and received the Gold Seal of Approval™, which is recognized nationwide as a symbol of quality that reflects a commitment to meeting high health care performance standards.

The Joint Commission accredits the broadest range of health care facilities, including health systems, office-based practices, ambulatory care facilities and hospitals.

Select Lifeline Vascular Access facilities underwent a thorough on-site evaluation of compliance with 150 standards that promote quality care and patient safety. The decision to pursue this voluntary process demonstrates the commitment to provide high-quality care in a safe environment. The on-site evaluations included observation in patient care areas, interviews with staff and patients, and reviews of documentation and selected medical records. Surveyors also looked at facility safety, security, treatment of hazardous wastes and materials, emergency preparedness, patient safety, equipment condition and utility systems.

Lifeline has been successful in developing a dialysis access management infrastructure that is uniquely suited to the pursuit of clinical excellence including research and presentations in the field. Lifeline provides comprehensive support for clinical centers in the key areas of patient care, research and education.

“This system-wide re-accreditation of our managed centers is further evidence of the quality care that has become synonymous with our name,” said Terry Litchfield, Vice President of Clinical Operations for Lifeline Vascular Access. “Our specialized teams across the country provide unparalleled access care to dialysis patients and make this re-accreditation a reality.”

 http://www.lifelinevascularaccess.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GLP-1 drugs protect brain health by improving neurovascular function and reducing inflammation